US Tech 100

19,174.00

1.14%

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

SLRN

ACELYRIN (SLRN)

ACELYRIN Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SLRN

1 2 3 Next >>

Date	Time	Source	Headline	Symbol	Company
06/11/2024	4:05PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SLRN	ACELYRIN Inc
06/05/2024	6:00AM	GlobeNewswire Inc.	ACELYRIN, INC. Announces Positive 16-week Data From its Global Phase 2b/3 Trial of Izokibep in Psoriatic Arthritis to be Shared During Late-Breaking Oral Presentation at EULAR 2024	NASDAQ:SLRN	ACELYRIN Inc
05/29/2024	6:00AM	GlobeNewswire Inc.	ACELYRIN, INC. Announces Lonigutamab Phase 1/2 Proof-Of-Concept Data to be Shared During Late-Breaking Oral Presentation at ENDO 2024	NASDAQ:SLRN	ACELYRIN Inc
05/28/2024	4:20PM	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:SLRN	ACELYRIN Inc
05/24/2024	6:12PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLRN	ACELYRIN Inc
05/24/2024	6:10PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLRN	ACELYRIN Inc
05/24/2024	6:06PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLRN	ACELYRIN Inc
05/17/2024	6:12PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLRN	ACELYRIN Inc
05/17/2024	6:09PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLRN	ACELYRIN Inc
05/17/2024	6:05PM	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:SLRN	ACELYRIN Inc
05/14/2024	3:22PM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SLRN	ACELYRIN Inc
05/09/2024	7:14AM	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:SLRN	ACELYRIN Inc
05/09/2024	7:13AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SLRN	ACELYRIN Inc
05/09/2024	7:01AM	GlobeNewswire Inc.	ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones	NASDAQ:SLRN	ACELYRIN Inc
05/09/2024	7:00AM	GlobeNewswire Inc.	ACELYRIN, INC. Announces Leadership Transition	NASDAQ:SLRN	ACELYRIN Inc
04/29/2024	3:05PM	GlobeNewswire Inc.	ACELYRIN, INC. to Report First Quarter 2024 Financial Results and Corporate Update on May 13, 2024	NASDAQ:SLRN	ACELYRIN Inc
03/28/2024	3:05PM	GlobeNewswire Inc.	ACELYRIN, INC. Reports Full Year 2023 Financial Results and Recent Highlights	NASDAQ:SLRN	ACELYRIN Inc
03/27/2024	3:01PM	GlobeNewswire Inc.	Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million	NASDAQ:SLRN	ACELYRIN Inc
03/20/2024	6:00AM	GlobeNewswire Inc.	ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept Data for Lonigutamab, First Subcutaneous Anti-IGF-1R to Demonstrate Clinical Responses in Thyroid Eye Disease	NASDAQ:SLRN	ACELYRIN Inc
03/11/2024	7:05AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SLRN	ACELYRIN Inc
03/11/2024	7:02AM	GlobeNewswire Inc.	ACELYRIN, INC. Announces Positive Top-line Results from Its Global Phase 2b/3 Clinical Trial of Izokibep in Psoriatic Arthritis	NASDAQ:SLRN	ACELYRIN Inc
03/11/2024	7:00AM	GlobeNewswire Inc.	ACELYRIN, INC. Announces Long-term 32-Week Data from the Phase 2b Trial of Izokibep in Hidradenitis Suppurativa Demonstrating Sustained Responses and Deepening Clinical Benefit - Improving Quality of Life for Patients	NASDAQ:SLRN	ACELYRIN Inc
02/15/2024	3:05PM	GlobeNewswire Inc.	ACELYRIN, INC. Appoints Agnes Lee as Senior Vice President, Investor Relations and Corporate Communications	NASDAQ:SLRN	ACELYRIN Inc
01/12/2024	4:45AM	PR Newswire (US)	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acelyrin, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 16, 2024 - (NASDAQ: SLRN)	NASDAQ:SLRN	ACELYRIN Inc
01/11/2024	5:38PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLRN	ACELYRIN Inc
01/11/2024	5:31PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLRN	ACELYRIN Inc
01/05/2024	4:45AM	PR Newswire (US)	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acelyrin, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 16, 2024 - (NASDAQ: SLRN)	NASDAQ:SLRN	ACELYRIN Inc
12/20/2023	3:38PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SLRN	ACELYRIN Inc
12/20/2023	3:30PM	GlobeNewswire Inc.	ACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors	NASDAQ:SLRN	ACELYRIN Inc
12/18/2023	4:45AM	PR Newswire (US)	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acelyrin, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 16, 2024 - (NASDAQ: SLRN)	NASDAQ:SLRN	ACELYRIN Inc